Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06604897
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
None
First Post:
2024-09-17
Brief Title:
Effectiveness of Entresto SacubitrilValsartan in Japanese Patients With Hypertension
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Effectiveness of Entresto SacubitrilValsartan to Blood Pressure Control in Japanese Patients With Hypertension the Database Analysis of Electronic Medical Records
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is a non-interventional secondary use of data retrospective cohort study and the data to be extracted in this study will be used as secondary use of collected patient information in the database Japan Medical Data Survey JAMDAS owned by M3 Inc JAMDAS is a database that aggregates medical information and is constructed mainly from electronic medical record information of general practices allowing real-time extraction of information entered in medical records such as prescription status including drug switching and continuation laboratory values clinical evaluation scores and comorbidities etc
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: